Deals
Sucampo Pharma to Make Tender Offer For Japan's R-Tech Ueno
This article is for subscribers only.
Sucampo Pharmaceuticals Inc. agreed to acquire Japan’s R-Tech Ueno Ltd. in a deal valued at about 33 billion yen ($276 million), buying a company controlled by Sucampo’s founders that manufactures all of its drugs.
Bethesda, Maryland-based Sucampo agreed to purchase 44 percent of R-Tech from the founders and a related entity for 1,400 yen per share, and is making a tender offer of 1,900 yen in cash for the rest of the company, it said in a statement today.